共 35 条
[1]
EGFR Mutation of Tumor and Serum in Gefitinib-Treated Patients with Chemotherapy-Naive Non–small Cell Lung Cancer[J] . Hideharu Kimura,Kazuo Kasahara,Kazuhiko Shibata,Takashi Sone,Akihiro Yoshimoto,Toshiyuki Kita,Yukari Ichikawa,Yuko Waseda,Kazuyoshi Watanabe,Hiroki Shiarasaki,Yoshihisa Ishiura,Masayuki Mizuguchi,Yasuto Nakatsumi,Tatsuhiko Kashii,Masashi Kobayashi,Hideo Kunitoh,Tomohide Tamura,Kazuto Nishio,Masaki Fujimura,Shinji Nakao.  Journal of Thoracic Oncology . 2006 (3)
[2]
Comparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancer
[J].
CANCER,
2007, 109 (09)
:1836-1844
Sone, Takashi
;
Kasahara, Kazuo
;
Kimura, Hideharu
;
Nishio, Kazuto
;
Mizuguchi, Masayuki
;
Nakatsumi, Yasuto
;
Shibata, Kazuhiko
;
Waseda, Yuko
;
Fujimura, Masaki
;
Nakao, Shinji
.
[3]
Epi-dermal growth factor receptor mutations in needle biopsy/aspira-tion samples predict response to Gefitinib therapy and survival of patients with advanced non small cell lung cancer. Jin-Yuan Shih,Chien-Hung Gow,Chong-Jen Yu1,et al. International Journal of Cancer . 2006
[4]
Epider-mal growth factor receptor gene mutation and computed tomo-graphic findings in peripheral pulmonary adenocarcinoma. Motoki Yano,Hidefumi Sasaki,Yoshihiro Kobayashi,et al. JThorac Oncol . 2006
[5]
EG-FR mutation is specific for terminal respiratory unit type adenocar-cinoma. Yasushi Yatabe,Takayuki Kosaka,Takashi Takahashi,et al. The American Journal of Surgical Pathology . 2005
[6]
Mu-tation and polymorphism in the EGFR-TK domain associated with lung cancer. Weiping Zhang,Laura P Stabile,Phouthone Keohavong,et al. J Thorac Oncol . 2006
[7]
EGFR and ErbB2mutation status in Japanese lung cancer patients. Hidefumi Sasaki,Shigeki Shimizu,Katsuhiko Endo,et al. International Journal of Cancer . 2006
[8]
Optimiza-tion of patient selection for Gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation,K-ras mutation,and Akt phosphorylation. Sae-Won Han,Tae-You Kim,Yoon Kyung Jeon,et al. Clinical Cancer Research . 2006
[9]
Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer:Molecular analysis of the IDEAL/INTACT gefitinib trials. Daphne W Bell,,Thomas J Lynch,Sara MHaserlat,et al. Journal of Clinical Oncology . 2005
[10]
Identification of EGFR kinase domain mutations among lung cancer patients in Chi-na:implication for targeted cancer therapy. Bao Ming QIN,Xiao CHEN,Jing De ZHU,et al. Cell Research . 2005